Anton Clarke Atwell
Director Ejecutivo en Claris Biotherapeutics, Inc. .
Cargos activos de Anton Clarke Atwell
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Claris Biotherapeutics, Inc.
 Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Director/Miembro de la Junta | 01/07/2018 | - |
| Director Ejecutivo | 01/07/2018 | - | |
| Presidente | 01/07/2018 | - |
Historial de carrera de Anton Clarke Atwell
Antiguos cargos conocidos de Anton Clarke Atwell.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Noveome Biotherapeutics, Inc.
 Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Director/Miembro de la Junta | - | - |
| Director Ejecutivo | - | - | |
| Presidente | - | - | |
| MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Roche Laboratories, Inc.
 Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Corporate Officer/Principal | - | - |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Corporate Officer/Principal | - | - |
| ENZON PHARMACEUTICALS, INC. | Ventas & Marketing | - | - |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Director de Operaciones | 01/01/2006 | - |
| Fundador | 21/10/2009 | - |
Estadísticas
Internacional
| Estados Unidos | 8 |
Operativa
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 7 |
| Distribution Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ENZON PHARMACEUTICALS, INC. | Health Technology |
| MERCK & CO., INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Lux Biosciences, Inc.
Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Laboratories, Inc. markets and sells pharmaceutical medications. The company is based in Nutley, NJ. | Distribution Services |
Noveome Biotherapeutics, Inc.
Noveome Biotherapeutics, Inc. BiotechnologyHealth Technology Noveome Biotherapeutics, Inc. develops novel biotherapeutic products that restore cell communication and system homeostasis. Its proprietary technology platform, derived from human placental cells, provides an exciting new approach to tissue regeneration and repair in a wide range of medical conditions and offers hope, especially in patients with maladies. The company was founded in 2001 by George L. Sing and William J. Golden and is headquartered in Pittsburgh, PA. | Health Technology |
Claris Biotherapeutics, Inc.
Claris Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Claris Biotherapeutics, Inc. engages in the manufacturing of drugs. The company was founded in 2018 and is headquartered in Jersey City, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Anton Clarke Atwell
- Experiencia
